Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CAS 1609

Known as: CAS-1609 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

4-hydroxynethyl-furoxan-3-carboxamide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1999
Review
1999
Heterocyclic NO prodrugs.
An overview of the different heterocyclic NO-releasing compounds is given. Mesoionic heterocycles like sydnone imines are one… Expand
Is this relevant?
1997
1997
Lysophosphatidylcholine stimulates leukocyte rolling and adherence in rat mesenteric microvasculature.
Synthetic exogenous lysophosphatidylcholine (LPC) was used to induce leukocyte-endothelial cell interaction, utilizing intravital… Expand
Is this relevant?
1995
1995
Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury.
We studied the effects of a novel organic nitric oxide (NO) donor, 4-hydroxymethyl-furazan-3-carboxylic acid-2-oxide (CAS-1609… Expand
Is this relevant?
1995
1995
Intracoronary nitric oxide improves postischemic coronary blood flow and myocardial contractile function.
In the present study a novel nitric oxide (NO) donor, CAS-1609, was utilized as a means of coronary NO replenishment in a canine… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE